JENNIFER ZONE: Open Payments
NPI 1558510768 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$376 in 4 payments from 4 companies in 2025. Trend: 2023 $25 · 2024 $87 · 2025 $376
Food & beverage: $376
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $122 |
| ABBVIE INC. | 1 | $114 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: Livdelzi, ENTYVIO, XIFAXAN.
Industry payments across PA — which companies pay providers there.
